John Sununu’s Senate Campaign Benefits from Rising Prices in Key Sectors

Financial Gains for Sununu Amid Rising Costs

John Sununu, a Republican contender for the U.S. Senate in New Hampshire, has reportedly seen financial benefits from increased prices in gas, food, and medicine, as disclosed in his campaign finance reports.

Sununu, who previously served in the Senate from 2003 to 2009, is re-entering the political arena where affordability is a key concern among voters. His financial profile reveals significant stock market investments, with a net worth estimated to be as high as $36.3 million. As global events, such as tariffs and the Iran conflict, have driven up prices, the value of Sununu’s investments has concurrently risen.

Impact of Oil and Gas Holdings

Sununu’s substantial investments in oil and gas exemplify this trend. The Iran war has disrupted the global oil supply, leading to increased gas prices. American companies, although less affected by the disruptions, have capitalized on the situation by charging higher prices, thus boosting their profits.

Sununu holds up to $50,000 in ExxonMobil and up to $65,000 in Shell. As gas prices soared for New Hampshire residents, the value of his gas investments surged by approximately 24% (source).

Despite the conflict’s unpopularity, Sununu has supported the Iran war. In March, he emphasized its importance on the New Hampshire Today radio show, citing benefits for national and economic security. He reiterated these sentiments in June, claiming the war’s continuation would be favorable to both the global and American economy.

Investments in the Food Sector

Sununu also holds significant investments in food retailers profiting from rising grocery costs. His portfolio includes up to $150,000 in Wal-Mart, up to $100,000 in PepsiCo, and an equal amount in Coca-Cola. Factors such as increased shipping costs and tariffs have contributed to higher food prices.

Following President Donald Trump’s tariffs, consumer prices rose, with food costs increasing by 2.4% in 2025, according to the Bureau of Labor Statistics (source). During this period, Sununu’s holdings in PepsiCo, Wal-Mart, and Coca-Cola increased by 4%, 34%, and 21%, respectively, realizing a combined growth of at least $50,000.

Sununu has downplayed the impact of these tariffs, describing their economic effects as “very modest” in September 2025. He later dismissed the Supreme Court’s ruling against the tariffs, indicating that alternative legislative measures still empower the president to impose them.

Pharmaceutical Industry Connections

Sununu’s investments extend to the pharmaceutical sector, with holdings up to $425,000 in companies like Pfizer and Merck. Despite a White House announcement in September 2025 about reducing drug prices, these companies subsequently increased their prices, including a 15% hike by Pfizer on its COVID vaccine.

Throughout his Senate tenure, Sununu opposed measures to lower drug costs, voting against Medicare negotiations and the importation of cheaper medications from Canada. Post-Senate, he worked as a lobbyist for Akin Gump, representing pharmaceutical giants Pfizer and Merck.

As Sununu prepares for a primary on September 8 against former Massachusetts Senator Scott Brown, the winner is expected to challenge Democratic Representative Chris Pappas in the upcoming November election.